Chapter 2

Toward Induced Pluripotent Stem Cells for Clinical Use: Sources, Methods and Selection

Maria P De Miguel, Adrian Moratilla, Alba Cabrera-Fisac and P Gonzalez- Molina

Abstract

Since their development by Yamanaka in 2007, much progress has been made in the last decade toward the use of human induced pluripotent stem cells (iPSCs) in clinical practice. In this review, we will focus on the various sources of somatic cells for human iPSC generation, the methods used for generating human iPSCs, their characterization, and the progress on directed differentiation toward several cell types. We will also describe current efforts to prevent culture-driven mutations and the selection of nontumorigenic cells for clinical use. A comprehensive comparison of such methods will aid in the establishment of standardized techniques and highlight areas in which further research is still needed.

Total Pages: 76-113 (38)

Purchase Chapter  Book Details

RELATED BOOKS

.Stem Cells in Clinical Application and Productization.
.Stem Cell Delivery Routes: From Preclinical Models to Clinical Applications.
.The Regeneration Promise: The Facts behind Stem Cell Therapies.
.Vascularization in Tissue Engineering.